Form 4 for IMNM Immunome Inc.
Accepted 2026-05-19 07:56:51 ET · period of report 2026-05-15 · accession 0001221590-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 07:56 | 2026-05-15 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $20.70 | +5,000 | 43.4K | +13% | +$103.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | P | A | 5,000 | $20.70 | 43,415 | D | — | — | (F1) The weighted average purchase price for the transaction report was $20.70, and the range of prices were between $20.645 and $20.72, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |